SB 876: Chimeric Antigen Receptor T-cell Therapy
GENERAL BILL by Berman
Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.
Effective Date: 1/1/2026
Last Action: 6/16/2025 Senate - Died in Banking and Insurance
Bill Text: Web Page | PDF
Last Action: 6/16/2025 Senate - Died in Banking and Insurance
Bill Text: Web Page | PDF
Senate Committee References:
- Banking and Insurance (BI)
- Judiciary (JU)
- Rules (RC)
Bill History
| Date | Chamber | Action |
|---|---|---|
| 2/19/2025 | Senate |
• Filed |
| 2/28/2025 | Senate |
• Referred to Banking and Insurance; Judiciary; Rules |
| 3/4/2025 | Senate |
• Introduced |
| 5/3/2025 | Senate |
• Indefinitely postponed and withdrawn from consideration |
| 6/16/2025 | Senate |
• Died in Banking and Insurance |